Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Some months the weight drops right back after menstruation
Mechanism of Action Cellular proliferation is the primary mechanism by which the AHK-Cu peptide exerts its regenerative effects on hair follicles
The Clinical Data: Everything Published So Far Phase 1 First-in-Human (Oral Formulation) Published: The Lancet, June 2025 Participants: 144 adults with overweight or obesity (BMI 25.039.9), no diabetes Duration: Up to 12 weeks Dosing: Once-daily oral amycretin, up to 2 50 mg Results: - 50 mg dose: 10.4% mean body weight change - 2 50 mg dose: 13.1% mean body weight change - Placebo: 1.2% 13% weight loss in 12 weeks
FDA Schedules July 2026 PCAC Review of BPC-157, TB-500, MOTs-C, KPV, Semax, Epitalon, DSIP The FDA Pharmacy Compounding Advisory Committee will review BPC-157, TB-500, MOTs-C, KPV, Semax, Epitalon and DSIP for the 503A bulks list in July 2026
Common clinical uses include antibiotic injections, hormone therapy such as testosterone, vitamin B12 injections, and anti-inflammatory medications
